Latest News of IBRX
Inhibrx: The Biotech Spinoff Poised For Big Gains
By Forbes |
1 month ago
An experienced investor shares insights on finding hidden gems in overlooked areas of the market, focusing on spinoff companies like Inhibrx Biosciences. With innovative biotech treatments targeting c...
Director Kristiina Vuori Purchases Shares of Inhibrx Biosciences Inc (INBX)
By Yahoo! Finance |
2 months ago
Inhibrx Biosciences Inc (NASDAQ:INBX) is a biotech company developing therapeutic candidates for various medical needs. Recent insider transactions show more buying than selling, indicating confidence...
ImmunityBio, Inc. (IBRX) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance |
4 months ago
ImmunityBio, Inc. announced the treatment of patients in the U.S. with ANKTIVA for BCG-unresponsive bladder cancer. The FDA approved this immunotherapy on April 22, 2024....